News
Mammary gland fibroblasts are highly plastic and transition through distinct states during development and disease. A new ...
Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...
Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...
Lung cancer can co-opt genes that normally help a fetus develop and evade the mother's immune system. And while these pregnancy-specific glycoproteins (PSGs) can get activated in the cancers of both ...
The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...
First-in-class examples of direct SHOC2 binders and modulators of SMP complex assembly identified with potential to block oncogenic RAS/MAPK pathway signaling SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE ...
2d
Medindia on MSNBlood Test Ends Pancreatic Cancer's Game of Hide and Seek!Blood tests with enzyme profiling diagnose pancreatic cancer in Stage I and Stage II * The method adds efficiency to cancer detection while delivering better performance than //prevailing biomarkers * ...
A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...
George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, “We are excited to share the results on this novel target in psoriasis. Our findings demonstrate that ART26.12 has effects ...
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results